---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-073189"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:40:08.796492+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Health Sciences Acquisitions Corp 2 extends SPAC deadline to Jan 6, 2023

## Summary
- Board elected to extend business combination deadline from Nov 6, 2022 to Jan 6, 2023.
- Extension is the first of up to three monthly extensions allowed by shareholder-approved amendment.
- If no business combination by Jan 6, 2023, Company must redeem shares and dissolve.

## SEC filing metadata
- accession: 0001213900-22-073189
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390022073189/0001213900-22-073189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390022073189/ea168831-8k_healthsci2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-073189
- JSON: https://secwatch.observer/filing/0001213900-22-073189.json
- Plain text: https://secwatch.observer/filing/0001213900-22-073189.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.